Could a Common Cholesterol Drug Lower Your Dementia Risk? A 130,000-Person Study Finds a Link
A nationwide Danish study of more than 132,000 people found a strong association between participants who took a popular cholesterol drug and a decreased risk of dementia.
A new study reveals that women who experience menopause at an earlier age may face a quicker decline in brain health and a higher risk of developing Alzheimer's disease decades later. The research, published in JAMA Network Open, tracked nearly 2,600 women for up to 18 years and found a connection between the age of menopause onset and cognitive decline, Alzheimer's risk, and brain structure changes.
Dr. Nikki Ramskill, a women's health expert, explained that menopause is a significant biological transition and understanding the age at which it occurs could provide crucial insights into a woman's long-term health. While the study shows an association, not a direct cause-and-effect, it highlights the importance of addressing other modifiable risk factors like blood pressure, cholesterol, and lifestyle habits to potentially reduce dementia risk.
Written by urgent.news from Newsweek's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.